MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-UK-05-0003759
Saintlife Pharmaceuticals Limited - pharma in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹45.01 Cr
▲ 26% YoY
Net profit · FY 2025
₹30.86 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹2.1 Cr
EBITDA margin 4.7%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹23 Lakh
Issued & subscribed
Open charges
₹31 Cr
Satisfied ₹3.56 Cr
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Saintlife Pharmaceuticals Limited
Data last updated:
Saintlife Pharmaceuticals Limited is a public limited company based in Dehradun, Uttarakhand, India, a subsidiary of Himalaya Meditek Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24100UR2016PLC007244. Its GSTIN is 05AAXCS4847F1ZU (Uttarakhand).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23 Lakh. It is led by directors including Sanjay Nandwani and Sunil Nandwani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 323 Central Hope Town Industrial Area Selaqui Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.01 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹30.86 Lakh (net margin 0.7%) and EBITDA of ₹2.1 Cr (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 24% over five years.
The company is associated with 1 brand: Saintlife Pharmaceuticals. As per MCA filings, the company has open charges of ₹31 Cr and satisfied charges of ₹3.56 Cr on record. Court records list 27 cases involving the company, including 3 filed by the company and 24 filed against it; 16 cases are pending.
Saintlife Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0003759). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saintlife-pharmaceuticals.business.site.
Company details
CIN U24100UR2016PLC007244
Registration Number 007244
Incorporation Date 10 August 2016
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Himalaya Meditek Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0003759
Recognitions & Rankings of Saintlife Pharmaceuticals
Contact details
Saintlife Pharmaceuticals Limited's registered office is in Dehradun, Uttarakhand. Its website is saintlife-pharmaceuticals.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address323 Central Hope Town Industrial Area Selaqui Dehradun, Uttarakhand, India – 248001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Saintlife Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Saintlife Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Saintlife Pharmaceuticals operates one associated brand: SAINTLIFE PHARMACEUTICALS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution operations in India. | saintlifepharmaceuticals.in |
Business activity
The main business activity of Saintlife Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Saintlife Pharmaceuticals Limited, buy the company report.
Financials of Saintlife Pharmaceuticals Limited
FY 2024 filings availableSaintlife Pharmaceuticals Limited reported revenue of ₹45.01 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹45.01 Cr ▲ 26%
Net profit · FY 2025
₹30.86 Lakh margin 0.7%
EBITDA · FY 2025
₹2.1 Cr margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 21%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 12%
5 years · compounded
▼ 13%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 26% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saintlife Pharmaceuticals Limited, buy the company report.
Board of directors of Saintlife Pharmaceuticals Limited
Saintlife Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Nandwani | Director | 04 Oct 2019 | 7 Years 1 Months | Current |
| Sunil Nandwani | Director | 04 Oct 2019 | 7 Years 1 Months | Current |
| Yash Nandwani | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Saintlife Pharmaceuticals Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| T. C. Health Care Private Limited | ₹45.32 Cr (FY 2025) | -40.0% | Modinagar, Uttar Pradesh, India | |||
| Saintlife Pharmaceuticals Limitedthis company | ₹45.01 Cr (FY 2025) | ₹30.86 Lakh | 0.7% | 26.0% | Dehradun, Uttarakhand, India | |
| Rhombus Pharma Pvt Ltd | ₹44.95 Cr (FY 2024) | 1.0% | Gandhinagar, Gujarat, India | |||
| Zenotech Laboratories Limited | ₹44.6 Cr (FY 2025) | 7.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Saintlife Pharmaceuticals Limited, buy the company report.
Auditor
Saintlife Pharmaceuticals Limited is audited by Chitwan Sharma & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chitwan Sharma & Associates | FY 2023 | 018718C |
Shareholding
The shareholding of Saintlife Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Saintlife Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹31 Cr
Satisfied charges
₹3.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2025 | 101065453 | Others | ₹10 Cr | Open | |
| 25 Nov 2022 | 100654089 | Others | ₹14 Cr | Open | |
| 25 Nov 2022 | 100654079 | Others | ₹7 Cr | Open | |
| 24 Sep 2020 | 100378834 | Others | ₹64.17 Lakh | Satisfied | |
| 24 Jan 2017 | 100074610 | Others | ₹2.92 Cr | Satisfied |
To see the full charge records of Saintlife Pharmaceuticals Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Saintlife Pharmaceuticals Limited has 27 court cases on record: 3 filed by Saintlife Pharmaceuticals, 24 filed against it. 16 cases are pending and 11 are disposed.
Total cases
27
Filed by the company
3
Filed against the company
24
Pending
16
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 27 | 24 | 16 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by M/S. Kleantech Engg. Systems Pvt.Ltd Through Viresh Chavan | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Radico Khaitan Limited | Disposed |
| District court, Alappuzha, Kerala | Criminal case | Filed against the company by an individual | Pending |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Kancheepuram, Tamil Nadu | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Saintlife Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Saintlife Pharmaceuticals Limited was last rated by Crisil on 04 Nov 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 04 Nov 2019 |
To see the full credit ratings and regulatory alerts of Saintlife Pharmaceuticals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saintlife Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saintlife Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAXCS4847F1ZU | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saintlife Pharmaceuticals Limited, buy the company report.
Recent activity
Saintlife Pharmaceuticals Limited has 9 board changes on record since 2016: 6 appointments and 3 cessations. The latest: Sumit Juneja ceased to be Director on 25 Oct 2021.
Charges
A charge with Others of Rs. 1,400.00 Lakh registered on 25 Nov 2022 with Charge ID 100654089 was modified on 19 Jun 2025.
Charges
A charge with Others of Rs. 700.00 Lakh registered on 25 Nov 2022 with Charge ID 100654079 was modified on 19 Jun 2025.
Charges
A charge with Others amounted to Rs. 1,000.00 Lakh with Charge ID 101065453 was registered on 29 Jan 2025.
AGM
Saintlife Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 24 Sep 2020 via Charge ID 100378834 with Others was fully satisfied on 14 Aug 2024.
Charges
A charge registered on 24 Jan 2017 via Charge ID 100074610 with Others was fully satisfied on 02 May 2024.
Filing
Saintlife Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Charges
A charge with Others amounted to Rs. 1,400.00 Lakh with Charge ID 100654089 was registered on 25 Nov 2022.
Charges
A charge with Others amounted to Rs. 700.00 Lakh with Charge ID 100654079 was registered on 25 Nov 2022.
Charges
A charge with Others of Rs. 64.17 Lakh registered on 24 Sep 2020 with Charge ID 100378834 was modified on 25 Nov 2022.
Charges
A charge with Others of Rs. 292.22 Lakh registered on 24 Jan 2017 with Charge ID 100074610 was modified on 25 Nov 2022.
Ceased
Sumit Juneja ceased to be Director.
11 earlier events are in the company report.
Frequently asked questions
Saintlife Pharmaceuticals is an active public limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 2016 (10+ years old) and is registered under CIN U24100UR2016PLC007244.
Saintlife Pharmaceuticals has 3 current directors:
- Sanjay Nandwani - Director
- Sunil Nandwani - Director
- Yash Nandwani - Director
The latest financial statements of Saintlife Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Saintlife Pharmaceuticals is 05AAXCS4847F1ZU, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Saintlife Pharmaceuticals is U24100UR2016PLC007244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saintlife Pharmaceuticals has 27 court cases on record: 3 filed by the company and 24 filed against it. 16 are pending.
Saintlife Pharmaceuticals was incorporated on 10 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Saintlife Pharmaceuticals by revenue are T. C. Health Care Private Limited, Rhombus Pharma Pvt Ltd, Zenotech Laboratories Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sumit Juneja ceased to be Director on 25 Oct 2021. Yash Nandwani was appointed as Director on 25 Oct 2021. Naresh Kumar Juheja ceased to be Director on 09 Oct 2019. Saintlife Pharmaceuticals has 9 board changes on record in total.
Yes, Saintlife Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0003759).
Saintlife Pharmaceuticals can be reached through the website saintlife-pharmaceuticals.business.site. Its registered office is in Dehradun, Uttarakhand, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages